Synta Pharmaceuticals Announces Presentations at the 2013 European Cancer Congress
Published: Sep 12, 2013
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced scheduled presentations at the 2013 ECCO-ESMO-ESTRO European Cancer Congress in Amsterdam, The Netherlands.
“Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels”
Help employers find you! Check out all the jobs and post your resume.